Page last updated: 2024-08-23

paroxetine and Addiction, Opioid

paroxetine has been researched along with Addiction, Opioid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, M; Billiard, M; Chalabreysse, M; Durst, P; Palazzolo, J; Peyrelong, JP; Vialle, A	1
Baumann, P; Begré, S; Cosendai-Savary, L; Eap, CB; Golay, KP; Jaquet-Rochat, S; Kosel, M; Ladewig, D; von Bardeleben, U	1

Other Studies

2 other study(ies) available for paroxetine and Addiction, Opioid

Article	Year
[Methadone and sleep apnea syndrome]. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3 Topics: Adult; Brain; Clonidine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Hydroxyzine; Methadone; Methotrimeprazine; Opioid-Related Disorders; Paroxetine; Polysomnography; Sleep Apnea, Central; Sleep Stages; Substance Withdrawal Syndrome; Trimeprazine	2005
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2 Topics: Adult; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Inactivation, Metabolic; Male; Metabolic Clearance Rate; Methadone; Opioid-Related Disorders; Paroxetine	2002

Article

Year

[Methadone and sleep apnea syndrome].

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3

Topics: Adult; Brain; Clonidine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Hydroxyzine; Methadone; Methotrimeprazine; Opioid-Related Disorders; Paroxetine; Polysomnography; Sleep Apnea, Central; Sleep Stages; Substance Withdrawal Syndrome; Trimeprazine

2005

Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers.

Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2

Topics: Adult; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Inactivation, Metabolic; Male; Metabolic Clearance Rate; Methadone; Opioid-Related Disorders; Paroxetine

2002